Citations (95)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Tingyun Xu, Yiwei Zhu, Shuaishuai Ge & Song-Bai Liu. (2023) The roles of TPL in hematological malignancies. Hematology 28:1.
Read now
Read now
Said Moshawih, Hui Poh Goh, Nurolaini Kifli, Mohammed Abd ElFattah Darwesh, Chrismawan Ardianto, Khang Wen Goh & Long Chiau Ming. (2023) Identification and optimization of TDP1 inhibitors from anthraquinone and chalcone derivatives: consensus scoring virtual screening and molecular simulations. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-25.
Read now
Read now
Lorenzo Ferro Desideri, Souska Zandi, Martin S Zinkernagel & Rodrigo Anguita. (2023) Challenges in proliferative vitreoretinopathy: is biological therapy a solution?. Expert Opinion on Biological Therapy 0:0, pages 1-3.
Read now
Read now
Shuntaro Miyake & Seiji Masuda. (2022) Inhibition of mitochondrial complex III or dihydroorotate dehydrogenase (DHODH) triggers formation of poly(A)+ RNA foci adjacent to nuclear speckles following activation of ATM (ataxia telangiectasia mutated). RNA Biology 19:1, pages 1244-1255.
Read now
Read now
Hong Zhou, Xiaofeng Jia, Fan Yang & Pengfei Shi. (2021) Long noncoding RNA SATB1-AS1 contributes to the chemotherapy resistance through the microRNA-580/ 2’-5’-oligoadenylate synthetase 2 axis in acute myeloid leukemia. Bioengineered 12:1, pages 6403-6417.
Read now
Read now
Adrian Christopher Jaramillo, Isabelle Hubeek, Richard Broekhuizen, Marçal Pastor-Anglada, Gertjan J. L. Kaspers, Gerrit Jansen, Jacqueline Cloos & Godefridus J. Peters. (2020) Expression of the nucleoside transporters hENT1 (SLC29) and hCNT1 (SLC28) in pediatric acute myeloid leukemia. Nucleosides, Nucleotides & Nucleic Acids 39:10-12, pages 1379-1388.
Read now
Read now
Louis S. Matza, Kristen A. Deger, Timothy A. Howell, Kimberly Koetter, Andrew M. Yeager, Donna Hogge, Vicki Fisher, Arthur C. Louie & Karen C. Chung. (2019) Health state utilities associated with treatment options for acute myeloid leukemia (AML). Journal of Medical Economics 22:6, pages 567-576.
Read now
Read now
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Miguel Ángel Sanz, José Luis Poveda & Pau Montesinos. (2019) Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review. Expert Review of Clinical Pharmacology 12:3, pages 197-218.
Read now
Read now
Articles from other publishers (87)
Xiaoyan Zhang, Lin Yang, Xiaojun Liu, Ziyuan Nie, Menghan Liu, Tianyang Wang, Yaqiong Lu, Yuxia Pan, Ying Zhan, Zhenzhen Wang & Jianmin Luo. (2024) Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1871:1, pages 119607.
Crossref
Crossref
Maryam Ahmed S. Al Barashdi, Ahlam Ali, Mary Frances McMullin & Ken Mills. (2023) CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy. Annals of Hematology.
Crossref
Crossref
Szymon Milnerowicz, Julia Maszewska, Paulina Skowera, Magdalena Stelmach & Monika Lejman. (2023) AML under the Scope: Current Strategies and Treatment Involving FLT3 Inhibitors and Venetoclax-Based Regimens. International Journal of Molecular Sciences 24:21, pages 15849.
Crossref
Crossref
Lin Zhang, Min Wu, Weikai Guo, Shuangshuang Zhu, Shen Li, Shiyi Lv, Yan Li, Layang Liu, Yajing Xing, Huang Chen, Mingyao Liu, Shihong Peng, Yihua Chen & Zhengfang Yi. (2023) A small molecule BCL6 inhibitor as chemosensitizers in acute myeloid leukemia. Biomedicine & Pharmacotherapy 166, pages 115358.
Crossref
Crossref
Sam Humphries, Danielle R. Bond, Zacary P. Germon, Simon Keely, Anoop K. Enjeti, Matthew D. Dun & Heather J. Lee. (2023) Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia. Clinical Epigenetics 15:1.
Crossref
Crossref
Renshuai Zhang, Xiaohua Zhao, Ang Jia, Chao Wang & Hongfei Jiang. (2023) Hyaluronic acid-based prodrug nanomedicines for enhanced tumor targeting and therapy: A review. International Journal of Biological Macromolecules 249, pages 125993.
Crossref
Crossref
Zinaida Stupakova, Iryna Diagil, Ulyana Melnyk, Oksana Karnabeda & Anna Sergeieva. (2023) Primary hemostasis dysfunctions and bleeding risk in newly diagnosed acute myeloid leukemia. Journal of Cancer Research and Clinical Oncology 149:11, pages 8167-8176.
Crossref
Crossref
Chieh-Chen Huang, Yuan-Hsin Lo, Yu-Jou Hsu, Yuan-Bin Cheng, Chia-Chi Kung, Cher-Wei Liang, Der-Chen Chang, Kang-Ling Wang & Chi-Feng Hung. (2023) Anti-Atopic Dermatitis Activity of Epi-Oxyzoanthamine Isolated from Zoanthid. Marine Drugs 21:8, pages 447.
Crossref
Crossref
Hongliang He, Mengmeng Long, Yifan Duan & Ning Gu. (2023) Prussian blue nanozymes: progress, challenges, and opportunities. Nanoscale 15:31, pages 12818-12839.
Crossref
Crossref
Thao M. Nguyen, Manasi Jambhrunkar, Sook S. Wong, David M. Ross, Paul Joyce, John W. Finnie, Jim Manavis, Kristen Bremmell, Melissa R. Pitman & Clive A. Prestidge. (2023) Targeting Acute Myeloid Leukemia Using Sphingosine Kinase 1 Inhibitor-Loaded Liposomes. Molecular Pharmaceutics 20:8, pages 3937-3946.
Crossref
Crossref
Sruti Prathivadhi-Bhayankaram, Muhannad Aboud Abbasi, Mahmoud Ismayl, Rosalyn I. Marar, Abdullah Al-Abcha, Edward El-Am, Ali Ahmad, Andres Daryanani Acevedo, Rama Ellauzi, Hector Villarraga, Jonas Paludo & Nandan Anavekar. (2023) Cardiotoxicities of Novel Therapies in Hematological Malignancies: Monoclonal Antibodies and Enzyme Inhibitors. Current Problems in Cardiology 48:8, pages 101757.
Crossref
Crossref
Atefe Rahmati, Alireza Mafi, Omid Vakili, Firooze Soleymani, Zahra Alishahi, Sheida Yahyazadeh, Yasaman Gholinezhad, Malihe Rezaee, Thomas P. Johnston & Amirhossein Sahebkar. (2023) Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways. Annals of Hematology.
Crossref
Crossref
Ghizlane Choukrani, Nienke Visser, Natasha Ustyanovska Avtenyuk, Mirjam Olthuis, Glenn Marsman, Emanuele Ammatuna, Harm Jan Lourens, Toshiro Niki, Gerwin Huls, Edwin Bremer & Valerie R. Wiersma. (2023) Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance. Cell Death Discovery 9:1.
Crossref
Crossref
Uttpal Anand, Abhijit Dey, Arvind K. Singh Chandel, Rupa Sanyal, Amarnath Mishra, Devendra Kumar Pandey, Valentina De Falco, Arun Upadhyay, Ramesh Kandimalla, Anupama Chaudhary, Jaspreet Kaur Dhanjal, Saikat Dewanjee, Jayalakshmi Vallamkondu & José M. Pérez de la Lastra. (2023) Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes & Diseases 10:4, pages 1367-1401.
Crossref
Crossref
Mubasshir Washif, Tasnim Ahmad, Md Bayejid Hosen, Md Ratul Rahman, Tomoya Taniguchi, Hiromori Okubo, Kouji Hirota & Ryotaro Kawasumi. (2023) CTF18-RFC contributes to cellular tolerance against chain-terminating nucleoside analogs (CTNAs) in cooperation with proofreading exonuclease activity of DNA polymerase ε. DNA Repair 127, pages 103503.
Crossref
Crossref
Akira Morimoto, Yoko Shioda, Kazuko Kudo, Hirokazu Kanegane, Toshihiko Imamura, Katsuyoshi Koh, Yoshiyuki Kosaka, Yuki Yuza, Atsuko Nakazawa, Akiko M. Saito, Tomoyuki Watanabe & Yozo Nakazawa. (2023) Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study. International Journal of Hematology 118:1, pages 107-118.
Crossref
Crossref
Xiancong Yang, Yaoyao Wang, Simin Rong, Jiayue An, Xiaoxu Lan, Baohui Yin, Yunxiao Sun, Pingyu Wang, Boyu Tan, Ye Xuan, Shuyang Xie, Zhenguo Su & Youjie Li. (2023) Gene SH3BGRL3 regulates acute myeloid leukemia progression through circRNA_0010984 based on competitive endogenous RNA mechanism. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Jinliang Xiao, Weilian Wang & Jiapeng Dan. (2023) Nalbuphine Suppresses Leukemia Stem Cells and Acts Synergistically with Chemotherapy
Drugs via Inhibiting Ras/Raf/Mek/Erk Pathway. Anti-Cancer Agents in Medicinal Chemistry 23:8, pages 922-928.
Crossref
Crossref
Wenlong Zhang, Bincan Jiang, Hecheng Zhu, Ailan Cheng, Can Li, Haoxuan Huang, Xuewen Li & Yirui Kuang. (2023) miR-33b in human cancer: Mechanistic and clinical perspectives. Biomedicine & Pharmacotherapy 161, pages 114432.
Crossref
Crossref
Nick Jeffery & Nicolas Granger. (2023) New insights into the treatment of meningoencephalomyelitis of unknown origin since 2009: A review of 671 cases. Frontiers in Veterinary Science 10.
Crossref
Crossref
Arata Matsuyama, Janet Beeler‐Marfisi, R. Darren Wood, Danielle Richardson, Jerome Calvalido, Anthony J. Mutsaers & Dorothee Bienzle. (2022) Treatment of myeloid neoplasia with doxorubicin and cytarabine in 11 dogs. Veterinary and Comparative Oncology 21:1, pages 54-61.
Crossref
Crossref
Chao Ma, Feng Li, Zhanfeng He, Song Zhao, Yang Yang & Zhuoyu Gu. (2023) Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology. Frontiers in Pharmacology 14.
Crossref
Crossref
Oishi Mukherjee, Sudeshna Rakshit, Geetha Shanmugam & Koustav Sarkar. (2023) Role of chemotherapeutic drugs in immunomodulation of cancer. Current Research in Immunology 4, pages 100068.
Crossref
Crossref
Elly Y Arwanih, Melva Louisa, Ikhwan Rinaldi & Septelia I Wanandi. (2022) Resistance Mechanism of Acute Myeloid Leukemia Cells Against Daunorubicin and Cytarabine: A Literature Review. Cureus.
Crossref
Crossref
Ki Hyun Bae, Fritz Lai, Betul Oruc, Motomi Osato, Qingfeng Chen & Motoichi Kurisawa. (2022) Self-Assembled Daunorubicin/Epigallocatechin Gallate Nanocomplex for Synergistic Reversal of Chemoresistance in Leukemia. International Journal of Molecular Sciences 24:1, pages 381.
Crossref
Crossref
Jun Li, Yanqing Huang, Yue Hou, Yan Gu, Chunhua Song & Zheng Ge. (2022) High efficacy of azacitidine combined with homoharringtonine, idarubicin, and cytarabine in newly diagnosed patients with AML: A single arm, phase 2 trial. Frontiers in Oncology 12.
Crossref
Crossref
Richard M. Stone. (2022) Consolidation chemotherapy in AML: Are we playing with a full deck of cards?. Best Practice & Research Clinical Haematology 35:4, pages 101408.
Crossref
Crossref
Atefeh Ghodrati, Javad Rahbar Shahrouzi, Ramin Nemati & Neda Pourjafari. (2022) Adsorptive Removal of Daunorubicin from Water by Graphene Oxide, Activated Carbon, and Multiwalled Carbon Nanotubes: Equilibrium and Kinetic Studies. Chemical Engineering & Technology 45:12, pages 2203-2210.
Crossref
Crossref
Evgeniy A. Zayats, Ilya V. Fateev, Maria A. Kostromina, Yulia A. Abramchik, Dmitry D. Lykoshin, Daria O. Yurovskaya, Vladimir I. Timofeev, Maria Ya. Berzina, Barbara Z. Eletskaya, Irina D. Konstantinova & Roman S. Esipov. (2022) Rational Mutagenesis in the Lid Domain of Ribokinase from E. coli Results in an Order of Magnitude Increase in Activity towards D-arabinose. International Journal of Molecular Sciences 23:20, pages 12540.
Crossref
Crossref
Yiyang Li, Wei Zhou, Xiangbing Meng, Sarina D. Murray, Long Li, Abby Fronk, Vanessa J. Lazaro-Camp, Kuo-kuang Wen, Meng Wu, Adam Dupuy, Kimberly K. Leslie & Shujie Yang. (2022) Utilizing an Endogenous Progesterone Receptor Reporter Gene for Drug Screening and Mechanistic Study in Endometrial Cancer. Cancers 14:19, pages 4883.
Crossref
Crossref
Alexander Zhang, Tanner Johnson, Diana Abbott, Tanit Phupitakphol, Jonathan A Gutman, Daniel A Pollyea & Yiannis Koullias. (2022) Incidence of Invasive Fungal Infections in Patients With Previously Untreated Acute Myeloid Leukemia Receiving Venetoclax and Azacitidine. Open Forum Infectious Diseases 9:10.
Crossref
Crossref
Biao Wang, Bang-Shun He, Xiao-Lan Ruan, Jiang Zhu, Rui Hu, Jie Wang, Ying Li, Yun-Huang Yang & Mai-Li Liu. (2022) An integrated microfluidics platform with high-throughput single-cell cloning array and concentration gradient generator for efficient cancer drug effect screening. Military Medical Research 9:1.
Crossref
Crossref
Abdel-Nasser El-ShorbagiSachin ChaudharyAnurag ChaudharyGarima AgarwalPrabhash Nath TripathiShweta DumogaAlaa Ali AljaradFatma MahmoudEsraa OmerRamesh Kumar GuptaMahmoud Hamed Mohamed. (2022) Marine Antineoplastic Templates: Clinical trials (I-III) and Motifs Carried via Antibodies to Target Specific Cancerous Tissues. Biomedical and Pharmacology Journal 15:2, pages 579-603.
Crossref
Crossref
Shweta Bisht, Manisha Nigam, Shyam S. Kunjwal, Plygun Sergey, Abhay Prakash Mishra & Javad Sharifi-Rad. (2022) Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting. Stem Cells International 2022, pages 1-28.
Crossref
Crossref
Débora Felícia Vieira Ramos, Rubia Isler Mancuso, Bruna Contieri, Adriana Duarte, Luciana Paiva, Jeferson de Melo Carrilho, Sara Teresinha Olalla Saad & Mariana Lazarini. (2022) Rac GTPases in acute myeloid leukemia cells: Expression profile and biological effects of pharmacological inhibition. Toxicology and Applied Pharmacology 442, pages 115990.
Crossref
Crossref
Garrett M. Dancik, Ioannis F. Voutsas & Spiros Vlahopoulos. (2022) Lower RNA expression of ALDH1A1 distinguishes the favorable risk group in acute myeloid leukemia. Molecular Biology Reports 49:4, pages 3321-3331.
Crossref
Crossref
Lina XU & Jian-Dong SONG. (2022) Crocin reversed the antitumor effects through up-regulation of MicroRNA-181a in cervical cancer cells. Food Science and Technology 42.
Crossref
Crossref
Dwi Wahyunianto Hadisantoso, Dody Ranuhardy, Wulyo Rajabto, Aulia Rizka, Lyana Setiawan, Ikhwan Rinaldi, Arif Mansjoer, Erni Juwita Nelwan & Hamzah Shatri. (2022) Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy. F1000Research 11, pages 495.
Crossref
Crossref
Dwi Wahyunianto Hadisantoso, Dody Ranuhardy, Wulyo Rajabto, Aulia Rizka, Lyana Setiawan, Ikhwan Rinaldi, Arif Mansjoer, Erni Juwita Nelwan & Hamzah Shatri. (2022) Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy. F1000Research 11, pages 495.
Crossref
Crossref
Mengmeng Liu, Xinmei Chen, Hang Chen, Xin Wu, Wei Fan & Jianming Chen. (2022) Nanotechnology-Based Drug Delivery System for Anticancer Active Ingredients from Traditional Chinese Medicines: A Review. The American Journal of Chinese Medicine 50:08, pages 2011-2032.
Crossref
Crossref
Hussain Mubarak Al-Aamri, Helen R. Irving, Christopher Bradley & Terri Meehan-Andrews. (2021) Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment. BMC Cancer 21:1.
Crossref
Crossref
Mei-chen Wan, Wen Qin, Chen Lei, Qi-hong Li, Meng Meng, Ming Fang, Wen Song, Ji-hua Chen, Franklin Tay & Li-na Niu. (2021) Biomaterials from the sea: Future building blocks for biomedical applications. Bioactive Materials 6:12, pages 4255-4285.
Crossref
Crossref
Ahmed A. H. Abdellatif & Abdullah Fahad Alsowinea. (2021) Approved and marketed nanoparticles for disease targeting and applications in COVID-19. Nanotechnology Reviews 10:1, pages 1941-1977.
Crossref
Crossref
Liang Wang, Chun Li, Fang Xu, Fang Cao, Bo Zhang, Jing Wang, Shen Wang, Li Chen, Na Li, Chenglin Liao & Hongjun Liu. (2021) Analysis of efficacy, safety and prognostic factors of DAC‑HAA treatment in Chinese pediatric patients with refractory or relapsed acute myeloid leukemia. Molecular and Clinical Oncology 15:6.
Crossref
Crossref
Pinkal M. Desai, Janice Brown, Saar Gill, Melham M. Solh, Luke P. Akard, Jack W. Hsu, Celalettin Ustun, Charalambos Andreadis, Olga Frankfurt, James M. Foran, John Lister, Gary J. Schiller, Matthew J. Wieduwilt, John M. Pagel, Patrick J. Stiff, Delong Liu, Irum Khan, Wendy Stock, Suman Kambhampati, Martin S. Tallman, Lawrence Morris, John Edwards, Iskra Pusic, Hagop M. Kantarjian, Richard Mamelok, Alicia Wong, Rodney Van Syoc, Lois Kellerman, Swapna Panuganti, Ramkumar Mandalam, Camille N. Abboud & Farhad Ravandi. (2021) Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia. Journal of Clinical Oncology 39:29, pages 3261-3272.
Crossref
Crossref
Mahdi Aalikhani, Mehrdad Alikhani, Fatemeh Shamsabadi, Morteza Oladnabi & Zahra Bazi. (2021) In silico drug repurposing for the treatment of heart diseases using gene expression data and molecular docking techniques. Biochemical and Biophysical Research Communications 572, pages 138-144.
Crossref
Crossref
Kenny Tang, Andre C Schuh & Karen WL Yee. (2021) 3+7 Combined Chemotherapy for Acute Myeloid Leukemia: Is It Time to Say Goodbye?. Current Oncology Reports 23:10.
Crossref
Crossref
Maria A. Kolesnikova, Aleksandra V. Sen'kova, Tatiana I. Pospelova & Marina A. Zenkova. (2021) Drug responsiveness of leukemic cells detected in vitro at diagnosis correlates with therapy response and survival in patients with acute myeloid leukemia. Cancer Reports 4:4.
Crossref
Crossref
Juan Zhang, Xuefeng Gao, Mingming Wei, Yonghui Li, Guang Yang, Cheng Yang & Li Yu. (2021) A novel epigenetic drug conjugating flavonoid and HDAC inhibitor confer suppression of acute myeloid leukemogenesis. Clinical Science 135:14, pages 1751-1765.
Crossref
Crossref
Eric Haines, Yuki Nishida, Michael I. Carr, Rafael Heinz Montoya, Lauren B. Ostermann, Weiguo Zhang, Frank T. Zenke, Andree Blaukat, Michael Andreeff & Lyubomir T. Vassilev. (2021) DNA-PK inhibitor peposertib enhances p53-dependent cytotoxicity of DNA double-strand break inducing therapy in acute leukemia. Scientific Reports 11:1.
Crossref
Crossref
Muhammad Saiful Rahman, Paulus Budiono Notopuro, Suprapto Ma'at, Made Putra Sedana & Arifoel Hajat. (2021) Difference Expressions CD34 in Acute Myeloid Leukemia Cell Culture in the Administration of Cytarabine-Daunorubicine Dose Standards. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 27:2, pages 143-146.
Crossref
Crossref
Flavia Cunha Vasconcelos, Paloma Silva de Souza, Thaís Hancio, Fernanda Costas Casal de Faria & Raquel Ciuvalschi Maia. (2021) Update on drug transporter proteins in acute myeloid leukemia: Pathological implication and clinical setting. Critical Reviews in Oncology/Hematology 160, pages 103281.
Crossref
Crossref
Jieying Wu, Ling Zhang, Yashu Feng, Bijay Khadka, Zhigang Fang & Jiajun Liu. (2021) HDAC8 promotes daunorubicin resistance of human acute myeloid leukemia cells via regulation of IL-6 and IL-8. Biological Chemistry 402:4, pages 461-468.
Crossref
Crossref
Jonason Yang, Nunki Hassan, Sheng Xiang Franklin Chen, Jayvee Datuin & Jenny Y. Wang. 2021. Acute Leukemias. Acute Leukemias.
Daphné Krzisch, Alexandra Zduniak, Elena‐Liana Veresezan, Sylvie Daliphard, Nathalie Contentin, Dominique Penther, Pascaline Etancelin, Fabrice Jardin & Vincent Camus. (2021)
Successful treatment of T/myeloid mixed‐phenotype acute leukemia with the translocation (10;11)(p13;q14)
PICALM/AF10
with 3 + 7 myeloid standard treatment: A case report
. Clinical Case Reports 9:3, pages 1507-1513.
Crossref
Crossref
Shuangbo Dai, Xiaoqing Zhang, Peng Zhang, Xuesong Zheng & Qiying Pang. (2020) Fentanyl inhibits acute myeloid leukemia differentiated cells and committed progenitors via opioid receptor‐independent suppression of Ras and STAT5 pathways. Fundamental & Clinical Pharmacology 35:1, pages 174-183.
Crossref
Crossref
Ai-Mei Liao, Bangrong Cai, Ji-Hong Huang, Ming Hui, Kyung-Ku Lee, Kwang Youl Lee & ChangJu Chun. (2021) Synthesis, anticancer activity and potential application of diosgenin modified cancer chemotherapeutic agent cytarabine. Food and Chemical Toxicology 148, pages 111920.
Crossref
Crossref
Soudeh Moghadasi, Fatemeh Pourrajab & Seyedhossein Hekmatimoghaddam. (2021) Ara-C elicits apoptosis and inhibits proliferation of human lymphoblastic leukemia Nalm6 cell lines by down regulation of HDAC3 and DNMT3B and up regulation of DNMT3A. Annals of Cancer Research and Therapy 29:1, pages 47-54.
Crossref
Crossref
Mariana Amaral, Ana B Pereiro, Maria Manuela Gaspar & Catarina Pinto Reis. (2021) Recent advances in ionic liquids and nanotechnology for drug delivery. Nanomedicine 16:1, pages 63-80.
Crossref
Crossref
Hung‐Sheng Shang, Chiung‐Ju Chen, Yung‐Luen Shih, Shu‐Fen Peng, Yung‐Liang Chen, Kuo‐Ching Liu, Hsieh‐Chou Huang, Shu‐Ching Hsueh, Kuo‐Wei Chen, Hsu‐Feng Lu, Mei‐Hui Lee, Ming‐Zhe Lee & Kung‐Wen Lu. (2020)
Mangiferin induces immune responses and evaluates the survival rate in
WEHI
‐3 cell generated mouse leukemia in vivo
. Environmental Toxicology 36:1, pages 77-85.
Crossref
Crossref
Do Van Chien, Pham Dang Hai, Le Thi Nhung & Pham Truong Son. (2020) Multiple spontaneous coronary artery dissections associated with intravenous daunorubicin treatment for acute myelocytic leukaemia: a case report. European Heart Journal - Case Reports.
Crossref
Crossref
Meng Liu, Yuan Ren, Xianfu Wang, Xianglan Lu, Ming Li, Young Mi Kim, Shibo Li & Lijun Zhang. (2020) Two rare cases of acute myeloid leukemia with t(8;16)(p11.2;p13.3) and 1q duplication: case presentation and literature review. Molecular Cytogenetics 13:1.
Crossref
Crossref
Sook-Kyoung Heo, Eui-Kyu Noh, Ho-Min Yu, Do Kyoung Kim, Hye Jin Seo, Yoo Jin Lee, Jaekyung Cheon, Su Jin Koh, Young Joo Min, Yunsuk Choi & Jae-Cheol Jo. (2020) Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death. BMC Cancer 20:1.
Crossref
Crossref
D.G.J. Cucchi, R.W.J. Groen, J.J.W.M. Janssen & J. Cloos. (2020) Ex vivo cultures and drug testing of primary acute myeloid leukemia samples: Current techniques and implications for experimental design and outcome. Drug Resistance Updates 53, pages 100730.
Crossref
Crossref
Doudou Yan, Hui Wei, Xinning Lai, Yangyang Ge, Shilin Xu, Jie Meng, Tao Wen, Jian Liu, Weiqi Zhang, Jianxiang Wang & Haiyan Xu. (2020) Co-delivery of homoharringtonine and doxorubicin boosts therapeutic efficacy of refractory acute myeloid leukemia. Journal of Controlled Release 327, pages 766-778.
Crossref
Crossref
Ludovic Gabellier, Caroline Bret, Guillaume Bossis, Guillaume Cartron & Jérôme Moreaux. (2020) DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets. Cancers 12:10, pages 2874.
Crossref
Crossref
Darina Ocadlikova, Clara Iannarone, Anna Rita Redavid, Michele Cavo & Antonio Curti. (2020) A Screening of Antineoplastic Drugs for Acute Myeloid Leukemia Reveals Contrasting Immunogenic Effects of Etoposide and Fludarabine. International Journal of Molecular Sciences 21:18, pages 6802.
Crossref
Crossref
Luyao Long, Yehuda G. Assaraf, Zi-Ning Lei, Hongwei Peng, Lin Yang, Zhe-Sheng Chen & Simei Ren. (2020) Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia. Drug Resistance Updates 52, pages 100703.
Crossref
Crossref
Fangli Chen, Xue Wu, Cristina Niculite, Marilena Gilca, Daniela Petrusca, Adriana Rogozea, Susan Rice, Bin Guo, Shawn Griffin, George A. Calin, H. Scott Boswell & Heiko Konig. (2020) Classic and targeted anti‐leukaemic agents interfere with the cholesterol biogenesis metagene in acute myeloid leukaemia: Therapeutic implications. Journal of Cellular and Molecular Medicine 24:13, pages 7378-7392.
Crossref
Crossref
Miho Maeda, Akira Morimoto, Yoko Shioda, Takeshi Asano, Yuhki Koga, Yozo Nakazawa, Hirokazu Kanegane, Kazuko Kudo, Shouichi Ohga & Eiichi Ishii. (2020) Long‐term outcomes of children with extracutaneous juvenile xanthogranulomas in Japan. Pediatric Blood & Cancer 67:7.
Crossref
Crossref
Charu Gupta, Stefan Kaulfuss, Kerstin Görlich, Basem Othman, Anuhar Chaturvedi & Michael Heuser. (2020) Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia. Annals of Hematology 99:6, pages 1415-1417.
Crossref
Crossref
Aniket Bankar, Anu Korula, Uday P. Kulkarni, Anup J. Devasia, Fouzia NA, Sharon Lionel, Aby Abraham, Poonkuzhali Balasubramanian, Nancy Beryl Janet, Sukesh C. Nair, Sezlian S, Visali Jeyaseelan, Jeyaseelan N, Jasmine Prasad, Biju George & Vikram Mathews. (2019) Resource utilization and cost effectiveness of treating acute promyelocytic leukaemia using generic arsenic trioxide. British Journal of Haematology 189:2, pages 269-278.
Crossref
Crossref
Nien‐Chieh Liao, Yung‐Luen Shih, Ming‐Tak Ho, Tai‐Jung Lu, Ching‐Hsiao Lee, Shu‐Fen Peng, Sy‐Jye Leu & Jing‐Gung Chung. (2019) Cardamonin induces immune responses and enhances survival rate in WEHI‐3 cell–generated mouse leukemia in vivo. Environmental Toxicology 35:4, pages 457-467.
Crossref
Crossref
Aleksandr Ianevski, Sanna Timonen, Alexander Kononov, Tero Aittokallio & Anil K. Giri. (2020) SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy. PLOS Computational Biology 16:2, pages e1007604.
Crossref
Crossref
Li Chen, Ning Hu, Chao Wang & Hongmian Zhao. (2020) HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells. Archives of Biochemistry and Biophysics 680, pages 108244.
Crossref
Crossref
Zinat Yazdani, Zahra Mousavi, Narges Ghasemimehr, Behjat Kalantary Khandany, Roya Nikbakht, Elham Jafari, Ahmad Fatemi & Gholamhossein Hassanshahi. (2020) Differential regulatory effects of chemotherapeutic protocol on CCL3_CCL4_CCL5/CCR5 axes in acute myeloid leukemia patients with monocytic lineage. Life Sciences 240, pages 117071.
Crossref
Crossref
Yanhui Liu, Pingchong Lei, Hong Qiao, Kai Sun, Xiling Lu, Fengchang Bao, Runhong Yu, Cheng Lian, Yao Li, Wei Chen & Fei Xue. (2019) MicroRNA‐33b regulates sensitivity to daunorubicin in acute myelocytic leukemia by regulating eukaryotic translation initiation factor 5A‐2. Journal of Cellular Biochemistry 121:1, pages 385-393.
Crossref
Crossref
Anna Orlova, Christina Wagner, Elvin D. de Araujo, Dávid Bajusz, Heidi A. Neubauer, Marco Herling, Patrick T. Gunning, György M. Keserű & Richard Moriggl. (2019) Direct Targeting Options for STAT3 and STAT5 in Cancer. Cancers 11:12, pages 1930.
Crossref
Crossref
G. Sicard, G. Venton, L. Farnault, R. Costello, R. Fanciullino & S. Gensollen. (2019) Mise en place d’un outil d’aide à la détection des interactions physico-chimiques en Y des médicaments injectables : analyse rétrospective des prescriptions dans un service d’hématologie. Le Pharmacien Hospitalier et Clinicien 54:4, pages 348-355.
Crossref
Crossref
Brent A. Williams, Arjun Law, Judit Hunyadkurti, Stephanie Desilets, Jeffrey V. Leyton & Armand Keating. (2019) Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats. Journal of Clinical Medicine 8:8, pages 1261.
Crossref
Crossref
Noelle Frey, Jun Ho Jang, Jeff Szer, Árpád Illés, Hee-Je Kim, Ron Ram, Beng H Chong, Jacob M Rowe, Elena Borisenkova, Jane Liesveld, Eric S Winer, Azzeddine Cherfi, Vassilios Aslanis, Farhat Ghaznawi & Stephen Strickland. (2019) Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 study. The Lancet Haematology 6:3, pages e122-e131.
Crossref
Crossref
Suqin Lv, Aihua Li, Haijuan Wu & Xiaoli Wang. (2019) Observation of clinical efficacy and toxic and side effects of pirarubicin combined with cytarabine on acute myeloid leukemia. Oncology Letters.
Crossref
Crossref
Fatemeh Farjadian, Amir Ghasemi, Omid Gohari, Amir Roointan, Mahdi Karimi & Michael R Hamblin. (2019) Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine 14:1, pages 93-126.
Crossref
Crossref
Margot K. Davis & Sean A. Virani. 2019. Heart Failure. Heart Failure
71
79
.
Enrico Derenzini, Alessandra Rossi & Davide Treré. (2018) Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why. Journal of Hematology & Oncology 11:1.
Crossref
Crossref
Huan Meng & Andre E. Nel. (2018) Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer. Advanced Drug Delivery Reviews 130, pages 50-57.
Crossref
Crossref
Eirinaios I Vrettos, Gábor Mező & Andreas G Tzakos. (2018) On the design principles of peptide–drug conjugates for targeted drug delivery to the malignant tumor site. Beilstein Journal of Organic Chemistry 14, pages 930-954.
Crossref
Crossref